Ebrief IV injection 20mg, manufactured by Recordati Rare Diseases Japan, contains Ibuprofen L-lysine, a nonsteroidal anti-inflammatory drug (NSAID). It is primarily used for the closure of a patent ductus arteriosus (PDA) in premature infants. YJ code: 2190417A1029, standard: 20mg 2mL 1 bottle.
Ebrief IV injection 20mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
